Skip to main content
Figure 3 | Breast Cancer Research

Figure 3

From: Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-α activation via the mitogen-activated protein kinase pathway

Figure 3

The total DNA content of mammary glands of parous rats treated with insulin-like growth factor (IGF)-I (P-IGF-I), untreated parous rats (P-Un), and age-matched virgin rats (AMV). The IGF-I treatment (0.66 mg/kg body weight/day) was continued for 7 days before samples were collected. Values are expressed as mean ± standard error. *P < 0.05 versus AMV and P-IGF-I.

Back to article page